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Summary
Objective: Free radical damage, inﬂammation, and apoptosis play a critical role in the onset and progression of cartilage erosion in arthritis.
Many studies have demonstrated that glycosaminoglycans (GAGs), and chondroitin-4-sulphate (C4S) in particular, possess antioxidant ac-
tivity that is able to inhibit lipid peroxidation which is the main mechanism of free radical-mediated biological injury. In addition to the effect
directly exerted by reactive oxygen species (ROS), the activation of nuclear factor kB (NF-kB) and caspases may contribute substantially
to increase inﬂammation and cell damage. We studied whether the antioxidant action of chronic C4S treatment to reduce ROS injury involves
NF-kB and caspases modulation using an experimental model of collagen-induced arthritis in mice.
Methods: Arthritis was induced in mice via an intradermal injection at the base of the tail of 100 ml of emulsion containing bovine type II
collagen in complete Freund’s adjuvant.
Results: Arthritis provoked the following: severe oedema and inﬂammation in the hind paws; lipid peroxidation in the joints [measured by
8-isoprostane (8-IPE) levels]; reduction of the endogenous antioxidants catalase (CAT) activity and reduced glutathione (GSH) levels; induc-
tion of NF-kB translocation; a loss of cytoplasmic NF-kB inhibitor alpha (IkBa); an increase in metalloproteinase-13 (MMP-13), caspase-3
and caspase-7 gene expression and their related protein; the induction of cartilage polymorphonuclear (PMN) activation and inﬁltration [eval-
uated by elastase (ELA) assay] and cartilage alterations evaluated by histological analysis. Intraperitoneal administration of different doses
of C4S (for 25 days), ameliorated all the symptoms of inﬂammation in the articular knee and paw joints, limited lipid peroxidation, inhibited
NF-kB activation and IkBa protein loss, decreased mRNA MMP-13 and caspases expression and their related protein, restored endogenous
antioxidants, and reduced PMN accumulation in the damaged cartilage.
Conclusion: The evidence that C4S was able to inhibit NF-kB and apoptosis activation supports the hypothesis that the C4S effect depends on
reduction of ROS production, although other direct effects cannot be excluded.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Arthritis isanautoimmunediseaseofunknownaetiology that is
characterized by the inﬁltration of lymphocytes and macro-
phages into the cartilage; hyperplasia of the cartilage lining;
enhanced angiogenesis and the destruction of cartilage
bone1. The pathogenesis of this disease is linked predomi-
nantly to the formation of free radicals at the site of inﬂamma-
tion2. Oxidative injury and the inﬂammatory state damage
components of the extra-cellular matrix (ECM) either directly
or indirectly byup-regulatingmediators ofmatrix degradation3.
Reactive oxygen species (ROS) inhibit the synthesis of matrix
components including proteoglycans by chondrocytes. In par-
ticular, ROS seem to inhibit type II collagen synthesis and the
sulphation of newly synthesized glycosaminoglycans
(GAGs)4. In addition, ROS can further damage the*Address correspondence and reprint requests to: Dr Giuseppe
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1474components of the ECM indirectly through the activation and
up-regulation of matrix metalloproteinases (MMPs)3.
Although the nuclear factor kB (NF-kB) plays an essential
and beneﬁcial role in normal physiology, the up-regulation
of this factor has been implicated in the pathogenesis of
several diseases including inﬂammatory and rheumatic dis-
eases5. The p50 and p65 NF-kB subunits are abundant in
rheumatoid and osteoarthritic cartilage. Animal models of
inﬂammatory arthritis also support the theory that NF-kB
plays a very active role in the development and progression
of arthritis in vivo6. NF-kB signalling pathways mediate crit-
ical events in the inﬂammatory response via chondrocytes,
leading to progressive ECM damage and cartilage destruc-
tion. Although oxidants are commonly considered to exert
their effects via a direct toxic action on target cells, recent
ﬁndings suggest their contributory role in gene induction.
NF-kB may, therefore, be activated by low levels of ROS
and inhibited by antioxidants7.
The dysregulation of apoptosis in the arthritic joint may
contribute to the progression of the disease. Caspases
are activated during the apoptotic process through a prote-
ase cascade, whereby the inactive pro-enzyme is cleaved
to form subunits of the active heterotetrameric protease8.
1475Osteoarthritis and Cartilage Vol. 16, No. 12The degradative phase of apoptosis is characterized by:
membrane blebbing, mitochondrial dysfunction, cellular
and cytoplasmic shrinkage and endonuclease activation
and ﬁnally by cellular disintegration into small vesicles
called apoptotic bodies9. A great deal of evidence indicates
that cell exposure to ROS induces apoptosis, which leads to
cell death and results in tissue damage and impaired func-
tion10. Apoptosis stimulated by different oxidant agents may
be inhibited by a number of antioxidant compounds11.
Most biological molecules have more than one function.
In particular, many molecules have the ability to directly/in-
directly scavenge free radicals and thus act as antioxidants
in living organisms. One of these structures is the GAG
chondroitin-4-sulphate (C4S), a biomolecule which has in-
creasingly focused the interest of many research groups
due to its antioxidant activity12,13. The increase of C4S
levels during oxidative stress seems to be a biological re-
sponse that may protect cells from oxidation in synergy
with the other antioxidant defence systems.
In the light of these ﬁndings, we investigated whether the
administration of C4S, previously evaluated in collagen-
induced arthritis (CIA) in rats14,15, involves NF-kB and
caspase modulation using a CIA model in mice.Materials and methodsANIMALSMalemiceDBA/16e7weeksoldwithameanweight of 25e30 gwereused in
ourstudy.Mice, purchased fromHarlan (Correzzana, Italy),weremaintainedun-
der climate-controlled conditions with a 12-h light/dark cycle. The animals were
fed standard rodent chow and water ad libitum. The health status of the animal
colony was monitored in accordance with Italian Veterinary Board guidelines.
Mice were divided into the following groups: (1) Control (n¼ 21); (2) C4S
(120 mg/kg) (n¼ 21); (3) CIA (n¼ 25); (4) CIAþC4S (30 mg/kg) (n¼ 21); (5)
CIAþC4S (60 mg/kg); (n¼ 21); (6) CIAþC4S (120 mg/kg) (n¼ 21).MATERIALSC4S, at medium molecular weight (approximately 18,000 Da), from bovine
trachea, approximately pure at 70% balanced with 30% C6S, was purchased
from SigmaeAldrich Srl (Milan, Italy). Bovine type II collagen and complete
Freund’s adjuvant were obtained from MD Biosciences (Zurich, Switzerland).
Mouse MMP-13 polyclonal antibodies were obtained from Chemicon Inter-
national, Inc. (Temecula, USA), caspase-3 and caspase-7 polyclonal anti-
bodies and, horseradish peroxidase-labelled goat anti-rabbit antibodies
were obtained from ImgenexCorporation (SanDiego, USA). All other reagents
used were purchased from Fluka (division of SigmaeAldrich Srl, Milan, Italy).INDUCTION OF CIA AND ARTHRITIS EVALUATIONMice were injected intradermally at the base of the tail 100 ml of 2.0 mg/ml
type II collagen emulsion in Freund’s complete adjuvant containing 2.5 mg/
ml heat-killed Mycobacterium tuberculosis H37Ra16. Mice were immunized
a second time 21 days later.
Evaluation of joint inﬂammation was carried out blindly by an independent
observer with no knowledge of the treatment protocol. The severity of the ar-
thritis in each limb was graded daily on a scale of 0e4 as follows: 0, no mac-
roscopic signs of arthritis; 1, swelling of one group of joints (i.e., wrist or ankle
joints); 2, two groups of swollen joints; 3, three groups of swollen joints; 4,
swelling of the entire limb. The maximum score for each rat was 16. Clinical
severity was also assessed by quantifying changes in limb volume. Mea-
surements were performed using a dial gauge caliper. At the end of the ex-
perimental period (day 45) mice were anaesthetized with ethyl ether and
then were sacriﬁced to remove their hind limbs.C4S SECTIONOn day 20, coincident approximately with the onset of CIA, the animals
were randomized to receive the treatments listed above in the Animals sec-
tion. C4S was dissolved in saline solution (0.9% NaCl) and administered in-
traperitoneally using a volume of 1.0 ml/kg body weight, once a day up until
day 45. The treatment of mice with C4S at 30, 60 and 120 mg/kg was chosenfor the following reasons: (1) The chondroitin sulphate (CS) dosage in hu-
mans is, on overage, 800 mg/day, that in a men weighing about 70 kg, corre-
sponds to about 11.5 mg/kg. The treatment with this dosage is protracted for
at least 10 months17e19. We related this treatment with the short period in
which our experiment was conducted, by administrating in 25 days the entire
dosage that could be administered for 10 or 12 mounts. (2) The second rea-
son was because we wanted to try a higher dosage than those we used in our
previous experiments, in order to evaluate the ratio of increase in dosage/im-
provement of the disease14,15. (3) The third reason was due to the high de-
gree tolerance showed by C4S, allowing the possibility to assess its activity
at high dosage without side effect or other pharmacological interferences18,20.NF-kB p50/65 TRANSCRIPTION FACTOR ASSAYNF-kB p50/65 DNA binding activity in nuclear extracts of cartilage tissue
samples was evaluated in order to measure the degree of NF-kB activation.
Analysis was performed in line with the manufacturer’s protocol for a com-
mercial kit (NF-kB p50/65 transcription factor assay colorimetric, cat. no.
SGT510, Chemicon International, USA). In brief, the hind limbs of the ani-
mals were removed at the end of the experimental phase and cartilage
was separated from bone and muscular tissue, washed in ice-cold 10 mM
TriseHCl, pH 7.4, and blotted on absorbent paper. Samples were then plot-
ted, by using an automatic plotter, in order to isolate cartilage cells. Cytosolic
and nuclear extraction was performed by lysing the cell membrane with an
apposite hypotonic lysis buffer containing protease inhibitor cocktail and trib-
utylphosphine (TBP) as reducing agent. After centrifugation the supernatant
containing the cytosolic portion of cell lysate was recovered and stored at
70C for successive analysis. The pellet containing the nuclear portion
was then resuspended in the apposite extraction buffer and the nuclei
were disrupted by a series of drawing and ejecting actions. The subsequent
analysis comprised a series of control steps accomplished by adding to the
nuclear extract HeLa whole cell extract [tumour necrosis factor alpha (TNF-
a) treated], transcription factor assay probe, NF-kB competitor oligonucleo-
tide and NF-kB capture probe. After incubation with primary and secondary
antibodies colour development was observed following the addition of the
substrate 1,2,4,5-tetramethylbenzidin (TMB/E). Finally, the absorbance of
the samples was measured using a spectrophotometric microplate reader
set at l 450 nm. Values are expressed as relative optical density (OD)/mg
protein.IkBa ASSAYIkBa loss was quantiﬁed in cartilage samples in order to conﬁrm NF-kB
activation. The test is based on solid phase sandwich enzyme-linked immu-
nosorbent assay (ELISA) assay. The cytosolic fraction, obtained during the
nuclei extraction procedure for NF-kB assay, was used for IkBa evaluation.
The assay was carried out using a commercial kit (IkBa, Total Human Bio-
Assay ELISA Kit, cat. no. 12500-05T, USBiological, USA). Values are
expressed as relative OD/mg protein.RNA ISOLATION, cDNA SYNTHESIS AND REAL TIME
QUANTITATIVE POLYMERASE CHAIN REACTION
(PCR) AMPLIFICATIONTotal RNA was isolated from cartilage tissue for reverse-PCR real time
analysis of MMP-13, caspase-3 and caspase-7 (RealTime PCR system,
Mod. 7500, Applied Biosystems, USA) using an Omnizol Reagent Kit (Euro-
clone, West York, UK). The ﬁrst strand of cDNA was synthesized from 1.0 mg
total RNA using a high capacity cDNA Archive kit (Applied Biosystems,
USA). b-actin mRNA was used as an endogenous control to allow the rela-
tive quantiﬁcation of MMP-13 and caspase mRNAs21. PCR real time was
performed by means of ready-to-use assays (Assays on demand, Applied
Biosystems) on both targets and endogenous controls. The amounts of
speciﬁc mRNA in samples were calculated from the standard curve, and
normalized with the b-actin mRNA. After normalization, the mean value of
normal cartilage cell target levels became the calibrator (one/sample) and
the results are expressed as the n-fold difference relative to normal controls
(relative expression levels).WESTERN BLOT ASSAY OF MMP-13, CASPASE-3
AND CASPASE-7 PROTEINSFor SDS-PAGE and Western blotting, the cartilage cells were washed
twice in ice-cold phosphate buffer saline (PBS) and subsequently dissolved
in SDS sample buffer (62.5 mM TriseHCl, pH 6.8, 2% w/v SDS, 10% glyc-
erol, 50 mM dithiothreitol, 0.01% w/v bromophenol blue). Aliquots of whole
cell protein extract (10e25 ml/well) were separated on a mini gel (10%). The
proteins were blotted onto polyvinylidene diﬂuoride membranes (Amersham
Biosciences) using a semi-dry apparatus (Bio-Rad). The membranes were
then incubated with the speciﬁc diluted (1:1000) primary antibody in 5%
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roller bottle. After being washed in three stages in wash buffer (1 PBS,
0.1% Tween 20), the blots were incubated with the diluted (1:2500) sec-
ondary polyclonal antibody (goat anti-rabbit conjugated with peroxidase),
in tris buffered saline (TBS)/Tween-20 buffer, containing 5% non-fat-dried
milk. After 45 min of gentle shaking, the blots were washed ﬁve times in
wash buffer, and the proteins, after coloration with 3,3-diaminobenzidin
(DAB) liquid substrate (SigmaeAldrich, Milan, Italy) were made visible us-
ing an UV/visible transilluminator (EuroClone, Milan, Italy) and Kodak Bio-
Max MR ﬁlms. A densitometric analysis was also run in order to quantify
each band.LIPID PEROXIDATION ESTIMATIONDetermination of 8-isoprostane (8-IPE) in the articular cartilage was
carried out to evaluate the extent of oxidation of cartilage phospholipids by
oxygen radicals. The analysis was performed using an EIA commercial kit
(8-Isoprostane EIA Kit, cat. no. 516351; Cayman Chemical Company, Ann
Arbor, USA). Values are expressed as relative OD/mg of protein.POLYMORPHONUCLEAR (PMN) ACTIVATIONElastase (ELA) activity was assayed as an index of neutrophil accumula-
tion and activation in cartilage tissue. The analysis was performed using
a ﬂuorometric commercial kit (Elastase Assay Kit, EnzChek, cat. no.
E12056, Invitrogen, Eugene, USA). Values are expressed as ﬂuorescent ar-
bitrary units (FAUs) at l Ex 480 nm and l Em 520 nm/mg protein.CATALASE (CAT) ANALYSIS100
) *
°AFor CAT activity, cartilage tissue was homogenized in a 1:10 (w/v) ratio
with an Ultra-Turrax homogenizer, maintained at 4C, in ice-cold 50 mM po-
tassium phosphate buffer pH 7.4. The homogenate was then centrifuged at
5000g for 10 min, and the supernatant (100 ml) was added to a tube con-
taining 10 ml of protease inhibitor cocktail and 0.1 mM EDTA sodium salt.
CAT activity was then assayed spectrophotometrically using a commercial
kit (Catalase-520, cat. no. 21042, OxisResearch, Portland, OR, USA). CAT
values are expressed as units/min/mg protein.iti
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**For GSH evaluation, cartilage tissue samples were homogenized in
a 1:10 (w/v) ratio using an Ultra-Turrax homogenizer, maintained at 4C, in
a solution containing 5% metaphosphoric acid (MPA) acid and 5 mM ethyl-
enediamine tetraacetic acid (EDTA). Each sample was then centrifuged at
6000g for 10 min at 4C. Biochemical analysis was performed using a spe-
ciﬁc colorimetric assay (Bioxytech GSH-400 Assay Kit, cat. no. 21011, Oxis-
Research, Portland, OR, USA). The amount of cartilage GSH was expressed
as nmol/mg protein.0
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At the end of the experimental phase, knee joints were removed from hind
limbs of the animals and ﬁxed in 10% buffered formalin. Knee joints were de-
calciﬁed in 5% formic acid, processed for parafﬁn embedding, sectioned at
5 mm thickness and subsequently stained with Safranin O for examination
under a light microscope (Optech Instrument, Munchen, Germany) con-
nected up to a digital camera (Coolpix 4500, Nikon, Japan).10
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**The amount of protein was determined using the Bio-Rad protein assay
system (Bio-Rad Laboratory, Richmond, CA, USA) with bovine serum albu-
min as a standard in accordance with the published method22.5ASTATISTICAL ANALYSIS0
CIA + C4S CIA + C4S
120 mg/kg 30 mg/kg
CTRL C4S CIA  CIA + C4S 
120 mg/kg60 mg/kgData are expressed as meansS.D. of no less than seven experiments
for each test. Statistical analysis was performed by one-way analysis of var-
iance (ANOVA) followed by the StudenteNewmaneKeuls test. The statisti-
cal signiﬁcance of differences was set at P< 0.05.Fig. 1. Effect of C4S treatment on the development (A) and progres-
sion (B) of arthritis at the end of experiment. Evaluation was per-STATEMENT OF ANIMAL CAREformed at the end of the experiment (day 60). Values are the
mean  S.D. of seven experiments. BP < 0.001 vs Control;
*P< 0.005 and **P< 0.001 vs CIA.The studies reported in this manuscript have been performed out in accor-
dance with the Helsinki declaration and the guidelines for the Care and Use
of Laboratory Animals.ResultsEFFECTS OF C4S ON CLINICAL SIGNS OF CIASome days after the second immunization, animals be-
gan to show evidence of clinical inﬂammation in one or
more hind paws. The ﬁrst manifestation of disease was er-
ythema of one or more ankle joints, followed by the metatar-
sal and interphalangeal joints. Figure 1(A) reports the
incidence of CIA over the 45-day study period. The initial
signs of arthritis in all groups were evident at day 25. In
the CIA group the percentage of mice developing arthritis
was 98.8 at day 25 and the same percentage was main-
tained until the end of the experiment. Treatment with
C4S signiﬁcantly attenuated the development of CIA: 76%
with the dose of 30 mg/kg; 54% with the dose of 60 mg/kg
and, and 40% with the dose of 120 mg/kg [Fig. 1(A)].
At the end of the experiment, the ﬁnal state of disease, as
assessed by the arthritis evaluation scale, is shown in
Fig. 1(B). By day 25 all animals showed evidence of the dis-
ease, predominantly in the hind paws. The disease was al-
ways progressive with joint recruitment following the same
pattern: tarsal, metatarsophalangeal followed by the inter-
phalangeal. The interphalangeal joints were never involved
alone, and inﬂammation in these joints was invariably asso-
ciated with inﬂammation in the tarsal joint. The arthritis
score in CIAþ vehicle group was progressive from day 25
and reached the score of about 12 in the last 4 days
1477Osteoarthritis and Cartilage Vol. 16, No. 12[Fig. 1(B)]. The same changes were observed in the hind
paw diameter of CIA animals. Administration of C4S signif-
icantly attenuated all clinical signs of arthritis.NF-kB DNA BINDING ACTIVITYFigure 2(A) shows the changes in NF-kB p50/65 hetero-
dimers in the nuclear extract of cartilage cells. NF-kB DNA
binding was present at very low levels in CIA-untreated car-
tilage cells, and the p50 subunit was more represented than
the p65 subunit. In contrast, NF-kB was markedly increased
in mice with CIA and also the ratio p50/p65 was inverted.0
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Fig. 2. Effect of C4S treatment on the articular cartilage NF-kB p50/65 tra
dation (B) in joints of mice with CIA. In panel A white bars represent the
meanS.D. of seven experiments and are expressed as OD at l 450
450 nm/mg protein (B). BP< 0.001 vs ContThe chronic treatment of mice with C4S resulted in a signif-
icant inhibition of NF-kB DNA binding. The effect was pos-
itive at all the doses used [Fig. 2(A)].LOSS OF IkBa PROTEIN IN THE CYTOPLASM OF CARTILAGE
CELLSNF-kB activation was also indirectly investigated by study-
ing its inhibitory protein IkBa in the cytoplasmof cartilagecells
[Fig. 2(B)]. Physiological levels of IkBa protein were assayed
in CIA-untreated mice, while arthritis produced a signiﬁcant
reduction in IkBa protein in the cytoplasm of cartilage cells.*
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1478 G. M. Campo et al.: C4S reduced NF-kB and caspase activation in experimental arthritisThe treatment of mice with C4S signiﬁcantly blunted the loss
of IkBa protein in the cytoplasm.MMP-13 mRNA EXPRESSION AND PROTEIN ACTIVITYMMP-13 was evaluated because of its active role in the
cartilage destruction [Fig. 3(AeC)]. Quantiﬁcation of gene
expression [Fig. 3(A)] showed that the mRNA of this
protein was not stimulated in CIA-untreated mice. However,
in the animals subjected to CIA MMP-13 expression was
signiﬁcantly up-regulated. The chronic administration of
C4S was able to reduce this increment in mRNA. The in-
crease in MMP-13 expression in arthritic mice correlated
well with the increment in protein synthesis. This correlation
also held for mice treated with C4S. In fact, the reduction inMMP-13 expression corresponded with a similar diminution
in protein formation [Fig. 3(B and C)].CASPASE-3 AND CASPASE-7 mRNA EXPRESSION
AND PROTEIN LEVELSThe apoptotic activators caspase-3 and caspase-7 were
evaluated by measuring mRNA expression and protein
activity in order to estimate apoptosis in cartilage tissue.
Caspase-3 [Fig. 4(A)] and caspase-7 [Fig. 5(A)] mRNA
evaluation and protein expression [Figs. 4(B and C) and
5(B and C)] in animals with CIA showed a marked increase
in the expression of the two apoptotic proteases. The treat-
ment of mice with C4S was able to reduce caspase-3 and
caspase-7 mRNA expression and new protein generation.
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and ***P< 0.001 vs CIA.
1479Osteoarthritis and Cartilage Vol. 16, No. 12Once again, caspase-3 and caspase-7 mRNA levels corre-
lated well with the protein concentrations obtained by West-
ern blot analysis.8-IPE EVALUATIONDetermination of 8-IPE in articular cartilage was carried
out in order to estimate the lipid peroxidation in the cartilage
tissue (Table I). Low levels of 8-IPE were measured in CIA-
untreated mice whereas, a signiﬁcant increment in this
marker was found in the joint cartilage of mice with CIA.
Chronic treatment with C4S was able to reduced 8-IPE
levels in the cartilage tissue.ELA ACTIVITYNeutrophil activation contributed to the progression and
the diffusion of inﬂammation in the cartilage tissue (Table I).
Very low ELA activity was measured in CIA-untreated mice.
In contrast, elevated ELA activity levels were assayed in
the CIA group. The administration of C4S was able to reduce
PMN accumulation in the cartilage as demonstrated by the
decreased ELA activity levels.ENDOGENOUS ANTIOXIDANTSThe CAT activity and total GSH levels (Table II) were as-
sayed in order to evaluate the endogenous antioxidant
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Fig. 5. Effect of C4S treatment on the articular cartilage caspase-7 mRNA expression (A) and related protein production (B, C) in joints of mice
with CIA. Values are the meanS.D. of seven experiments and are expressed as the n-fold increase with respect to the Control (A) and as
both densitometric analysis (C) and Western blot analysis (B) for the caspase-7 protein levels. BP< 0.001 vs Control; *P< 0.05, **P< 0.005
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Table I
Effect of C4S treatment on the articular cartilage 8-IPE content and
ELA levels in joints cartilage of mice with CIA
Experimental group 8-IPE ELA
Control 1.3 0.2 0.27 0.05
C4S (120 mg/kg) 1.5 0.3 0.25 0.04
CIA 37.8 7.4B 2.78 0.37B
CIAþC4S (30 mg/kg) 24.2 6.2* 2.11 0.32*
CIAþC4S (60 mg/kg) 16.5 4.7** 1.81 0.30**
CIAþC4S (120 mg/kg) 9.6 4.1** 1.73 0.34**
Values are the meanS.D. of seven experiments and are ex-
pressed as pg/mg protein for 8-IPE and as FAUs at l Ex 480 nm
and l Em 520 nm/mg protein for ELA. BP< 0.001 vs Control;
*P< 0.005 and **P< 0.001 vs CIA.
Table II
Effect of C4S treatment on the articular cartilage CAT activity and
reduced GSH levels in joints of mice with CIA
Experimental group CAT Reduced GSH
Control 120.3 15.2 8.8 1.8
C4S (120 mg/kg) 123.1 17.4 8.5 1.8
CIA 50.6 8.3B 3.2 0.8B
CIAþC4S (30 mg/kg) 71.2 9.1* 5.8 1.4*
CIAþC4S (60 mg/kg) 83.7 9.5** 6.4 1.5**
CIAþC4S (120 mg/kg) 94.8 10.3** 7.2 1.6**
Values are the mean S.D. of seven experiments and are ex-
pressed as units/min/mg protein for CAT and as nmol/mg protein for
reduced GSH. BP< 0.001 vs Control; *P< 0.005 and **P< 0.001
vs CIA.
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CIA + C4S
30 mg/kg
CIA + C4S
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CIA + C4S
120 mg/kg
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A
B
C
D
E
F
C
JS
C
F
Fig. 6. Effect of C4S on matrix proteoglycan loss and erosion in joint cartilage. C, cartilage; F, femur; JS, joint space. Safranin O 150.
1481Osteoarthritis and Cartilage Vol. 16, No. 12defences after CIA. A signiﬁcant reduction in both these an-
tioxidants was observed in the cartilage tissue obtained
from mice subjected to CIA. Once again, the treatment
with C4S signiﬁcantly restored CAT and GSH activities.HISTOLOGICAL ANALYSISFigure 6 reports a representative joint histopathology of
all the experimental groups considered. Panels A and B
1482 G. M. Campo et al.: C4S reduced NF-kB and caspase activation in experimental arthritisshow a knee joint section from CIA-untreated mice. The
fully stained cartilage layers indicate no loss of proteogly-
cans or erosion. Panel C presents a joint section from
a CIA-treated mouse. This clearly shows the severe knee
joint inﬂammation and complete loss of Safranin O staining
of the cartilage layers (indicated by arrows). In panels D, E,
and F a representative selection of knee joint sections joints
from mice receiving CIA and C4S treatment shows that
a gradual reduction in proteoglycan depletion and cartilage
erosion occurred (Fig. 6).Discussion
Arthritis is a disease affecting all the entire system, al-
though the skeletal apparatus is the principal target such
as the joint, including the cartilage, the subchondral bone,
and the periarticular tissues. The metabolic and structural
changes in the articular cartilage are thought to play a lead-
ing role in the initiation and the progression of the disease
process. The pathogenesis of arthritis is multifactorial and
several factors are involved. A number of authors have fo-
cused their attention on ROS as potent mediators of carti-
lage erosion23e25. Cartilage degradation, which is likely to
be driven by biomechanical factors, results in an imbalance
between catabolic and anabolic activities. MMPs and ROS
are the two main agents of matrix component degradation.
Theyhavebeen found tobeoverproduced inarthritic cartilage.
Modulation of NF-kB activation could be an important
strategy to reduce cellular injury. There is in fact increasing
evidence to suggest that NF-kB is an important mediator in
the pathophysiology of diseases characterized by elevated
levels of cytokines and ROS such as sepsis and inﬂamma-
tion26. ROS are also involved in the regulation of interleukin-
1 (IL-1) effects mediated by NF-kB. NF-kB up-regulates
genes (including MMPs) that are involved in cartilage deg-
radation. This degradation involves the enhanced cleavage
of type II collagen by collagenases, particularly collage-
nase-3 (MMP-13). This is associated with increased type
II collagen denaturation27. Several antioxidant compounds
have been found to be able to reduce NF-kB activation
with a consequent reduction in cell damage23,28.
Oxidative stress is able to produce many intracellular
events including apoptosis. There are two major pathways
via which apoptosis is induced; one involves death recep-
tors and is exempliﬁed by Fas-mediated caspase-8 activa-
tion, and the other is the stress- or mitochondria-mediated
caspase-9 activation pathway. Both pathways converge
on caspase-3 and caspase-7 activation, resulting in nuclear
degradation and cellular morphological change. Oxidative
stress induces cytochrome c release from mitochondria
and activation of caspases, p53, and kinases29. Apoptosis
contributes heavily to cell death in rheumatoid arthritis
(RA)30,31. It has been reported that molecules capable of
scavenging ROS may reduce apoptosis activation and
chondrocyte disruption24,32.
It has been suggested that CSs inhibit ROS production13.
CSs are the most abundant GAGs present in the human or-
ganism, and they can be localized anywhere in connective
tissues. Moreover, CSs are the most common components
of circulating GAGs. They are also constituents of normal
urine, andarepresent in leukocytes andplatelets. Thesemol-
eculesmay be distinguishable as a function of their degree of
sulphation at the C-4 or C-6 positions of galactosamine. C4S
has exhibited the greatest antioxidant effect of CS12,33.
In the present study the treatment of arthritic mice with dif-
ferent doses of C4Swas able to prevent cell damage inducedby CIA treatment as shown in our previous experiments on
different type of animal14,15. In addition to the antioxidant ef-
fect of this GAG, the focus of this study was the C4S activity
onNF-kB and executioner caspasesmodulation.We hypoth-
esize that the inhibition of NF-kB DNA binding to the nucleus
is probably the consequence of C4S reduced ROS produc-
tion in articular cartilage. NF-kB activation requires sequen-
tial phosphorylation, and degradation of IkBa, which
disappears from the cytoplasm in the end. Since ROS are
able to activate this pathway, then C4S is also supposed to
prevent the loss of the inhibitory protein from the cytoplasm
by preventing the oxidative burst. Although several papers
have reported that CS may also directly inhibit NF-kB activa-
tion and apoptosis34,35, we suggest that the same CS mech-
anism hypothesized for NF-kB DNA binding exerted by ROS
may be extended to apoptosis activation. In fact, the reduc-
tionof oxidative stresswasable to limit the caspaseactivation
pathway. C4S thereby reduced damage not only by reducing
ROS generation, but also by inhibiting NF-kB and apoptosis
activation that contributes greatly to exacerbate pathological
conditions in diseases. It has beenhypothesized thatC4Sex-
erted its antioxidant effect by chelating transition metal ions,
since Haber-Weiss and Fenton reactions are primed by tran-
sition metal ions such as Feþþ, the effect of the chelation of
this metal ion reduces oxidative stress by eliminating the
products of this reaction, and it is reasonable to hypothesize
that acting by blocking this reaction is more efﬁcient than
scavenging the reactive activity of the products formed. In
this way, C4S activity would be more efﬁcient than a conven-
tional antioxidant, because the inhibition of theoxidativeburst
does not prime NF-kB and apoptosis. If this were so, the an-
tioxidant effect of C4Swould be independent fromNF-kB and
caspaseactivation. Since the treatment ofmicewithC4Swas
able to protect chondrocytes from oxidative injury and also to
inhibit NF-kB DNA binding and apoptosis with two separate
mechanisms, this study suggests that the antioxidant effect
of C4S is due to the blocking ofHaber-Weiss andFenton’s re-
actions by metal ion chelation. Nevertheless, cannot be also
excluded that C4Smay exert a direct effect onNF-kB and ap-
optosis inhibition. Additional future investigations are needed
to conﬁrm this further hypothesis. Therefore, since in arthritis
injury several different pathways are involved, the antioxidant
hypotesis is one potential mechanism worthy of interest.Conﬂict of interest
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